University Institute of Pathology

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


2270 publications

In press | 2024 | 2023 | 2022 | 2021 | ...
 
Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy.
Berezowska S., Keyter M., Bouchaab H., Weissferdt A. Advances in anatomic pathology. Peer-reviewed.
 
Cytologic features of mesenchymal, melanocytic and haematolymphoid tumours of the central nervous system and metastases.
Bárcena C., Jiménez-Heffernan J.A. Cytopathology. Peer-reviewed.
 
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Camus V., Thieblemont C., Gaulard P., Cheminant M., Casasnovas R.O., Ysebaert L., Damaj G.L., Guidez S., Pica G.M., Kim W.S. et al. Journal of clinical oncology. Peer-reviewed.
 
PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation.
Chmiest D., Podavini S., Ioannidou K., Vallois D., Décaillet C., Gonzalez M., Quadroni M., Blackney K., Schairer R., de Leval L.L. et al. Blood advances. Peer-reviewed.
 
Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
Ducatel A., Trillaud H., Reizine E., Vilgrain V., Sempoux C., Schmidt-Kobbe S., Gouw ASH, de Haas R.J., Julien C., Paradis V. et al. European radiology. Peer-reviewed.
 
The enigma of glutamine synthetase and b-catenin expression in hepatocellular adenoma in familial adenomatous polyposis coli.
Gouw ASH, Sempoux C., Bioulac-Sage P. Virchows Archiv. Peer-reviewed.
 
Swiss digital pathology recommendations: results from a Delphi process conducted by the Swiss Digital Pathology Consortium of the Swiss Society of Pathology.
Janowczyk A., Zlobec I., Walker C., Berezowska S., Huschauer V., Tinguely M., Kupferschmid J., Mallet T., Merkler D., Kreutzfeldt M. et al. Virchows Archiv. Peer-reviewed.
 
Recurrent benign fibrous histiocytoma of the bone benefits from denosumab followed by malignant transformation: a case report.
Laureline W., Patrick O., Tu N., Stephane C., Ana D., Daniela F., Chiara S., Igor L., Antonia D. Skeletal radiology. Peer-reviewed.
 
WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M. Progres en urologie. Peer-reviewed.
 
Near-real-time Mueller polarimetric image processing for neurosurgical intervention.
Moriconi S., Rodríguez-Núñez O., Gros R., Felger L.A., Maragkou T., Hewer E., Pierangelo A., Novikova T., Schucht P., McKinley R. International journal of computer assisted radiology and surgery. Peer-reviewed.
 
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.
Poon L., de Leval L., Ng S.B., Song Y., Pro B., Savage K.J., Ruan J., Mehta-Shah N., Vose J.M. Hematological oncology. Peer-reviewed.
 
Cytologic features of meningioma: An analysis of common and uncommon subtypes and diagnostic difficulties during intraoperative procedures.
Rodríguez-García A.M., Esteban-Rodríguez I., Jiménez-Heffernan J.A., Bárcena C., López-Muñoz S., López-Ferrer P. Cytopathology. Peer-reviewed.
 
Primary hepatocellular carcinoma of the spleen.
Saglietti C., Fasquelle F., Barcena C., Schmidt S., Shirata C., Uldry E., Halkic N., Sempoux C. Pathology. Peer-reviewed.
 
Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R., Bisig B., Guey B., Missiaglia E., Cairoli A., Omoumi P., Letovanec I., Ferry J.A., Hasserjian R.P., de Leval L. Modern pathology. Peer-reviewed.
 
Editorial for "Beta-Catenin-Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI: A Systematic Review and Meta-Analysis".
Schmidt S., Sempoux C. Journal of magnetic resonance imaging. Peer-reviewed.
 
A new, deep learning-based method for the analysis of autopsy kidney samples used to study sex differences in glomerular density and size in a forensic population.
Vilmont V., Ngatchou N., Lioux G., Kalucki S., Brito W., Burnier M., Rotman S., Lardi C., Pruijm M. International journal of legal medicine. Peer-reviewed.
EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics.
Hench J., Hultschig C., Brugger J., Mariani L., Guzman R., Soleman J., Leu S., Benton M., Stec I.M., Hench I.B. et al., 2024/04/04. Acta neuropathologica communications, 12 (1) p. 51. Peer-reviewed.
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
Vicino A., Hottinger A.F., Latifyan S., Boughdad S., Becce F., Prior J.O., Kuntzer T., Brouland J.P., Dunet V., Obeid M. et al., 2024/04. Journal of neurology, 271 (4) pp. 1947-1958. Peer-reviewed.
 
Closing the scissor-shaped curve: Strategies to promote gender equality in academia.
Joyce J.A., Masina S., Michalik L., Pot C., Sempoux C., Amati F., 2024/03/14. Cell, 187 (6) pp. 1335-1342. Peer-reviewed.
Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
Bejarano L., Kauzlaric A., Lamprou E., Lourenco J., Fournier N., Ballabio M., Colotti R., Maas R., Galland S., Massara M. et al., 2024/03/11. Cancer cell, 42 (3) pp. 378-395.e10. Peer-reviewed.
 
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.
Barras D., Ghisoni E., Chiffelle J., Orcurto A., Dagher J., Fahr N., Benedetti F., Crespo I., Grimm A.J., Morotti M. et al., 2024/02/02. Science immunology, 9 (92) pp. eadg7995. Peer-reviewed.
Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E., Milowich D., Lemonnier F., Bisig B., Robe C., Pelletier L., Letourneau A., Dupuy A., Sako N., Ketterer N. et al., 2024/02. Histopathology, 84 (3) pp. 556-564. Peer-reviewed.
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers.
Hofman P., Berezowska S., Kazdal D., Mograbi B., Ilié M., Stenzinger A., Hofman V., 2024/02. Virchows Archiv, 484 (2) pp. 233-246. Peer-reviewed.
Erratum to: Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization.
Savage K.J., De Leval L., 2024/02/01. Haematologica, 109 (2) pp. 693-694. Peer-reviewed.
 
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
Dacic S., Cao X., Bota-Rabassedas N., Sanchez-Espiridion B., Berezowska S., Han Y., Chung J.H., Beasley M.B., Dongmei L., Hwang D. et al., 2024/02. Journal of thoracic oncology, 19 (2) pp. 273-284. Peer-reviewed.
 
Intraoperative in vivo confocal laser endomicroscopy imaging at glioma margins: can we detect tumor infiltration?
Xu Y., Mathis A.M., Pollo B., Schlegel J., Maragkou T., Seidel K., Schucht P., Smith K.A., Porter R.W., Raabe A. et al., 2024/02/01. Journal of neurosurgery, 140 (2) pp. 357-366. Peer-reviewed.
 
Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
Chapellier P., Fasquelle F., Saglietti C., Kinj R., Mantziari S., Schäfer M., Haefliger L., Jreige M., Vietti Violi N., Sempoux C. et al., 2024/02. European journal of radiology, 171 p. 111263. Peer-reviewed.
When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report.
Tripathy D., Moulin A., Bijon J., Gengler C., Beck-Popovic M., Munier F.L., Stathopoulos C., 2024/01/30. BMC ophthalmology, 24 (1) p. 47. Peer-reviewed.
CIC-DUX4 Chromatin Profiling Reveals New Epigenetic Dependencies and Actionable Therapeutic Targets in CIC-Rearranged Sarcomas.
Bakaric A., Cironi L., Praz V., Sanalkumar R., Broye L.C., Favre-Bulle K., Letovanec I., Digklia A., Renella R., Stamenkovic I. et al., 2024/01/21. Cancers, 16 (2) p. 457. Peer-reviewed.
DisP-seq reveals the genome-wide functional organization of DNA-associated disordered proteins.
Xing Y.H., Dong R., Lee L., Rengarajan S., Riggi N., Boulay G., Rivera M.N., 2024/01. Nature biotechnology, 42 (1) pp. 52-64. Peer-reviewed.
Impact of template-based synoptic reporting on completeness of surgical pathology reports.
Schaad N., Berezowska S., Perren A., Hewer E., 2024/01. Virchows Archiv, 484 (1) pp. 31-36. Peer-reviewed.
 
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors.
Gonvers S., Martins-Filho S.N., Hirayama A., Calderaro J., Phillips R., Uldry E., Demartines N., Melloul E., Park Y.N., Paradis V. et al., 2024. Journal of hepatocellular carcinoma, 11 pp. 707-719. Peer-reviewed.
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma - morphology, molecular characteristics and differential diagnosis.
Berezowska S., Maillard M., Keyter M., Bisig B., 2024/01. Histopathology, 84 (1) pp. 32-49. Peer-reviewed.
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient.
Anchisi S., Wolfer A., Bisig B., Missiglia E., Tiab A., Kamel E.M., Michielin O., Coukos G., Homicsko K., 2023/12/31. Cancer biology & therapy, 24 (1) p. 2193116. Peer-reviewed.
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.
Calderaro J., Ghaffari Laleh N., Zeng Q., Maille P., Favre L., Pujals A., Klein C., Bazille C., Heij L.R., Uguen A. et al., 2023/12/14. Nature communications, 14 (1) p. 8290. Peer-reviewed.
 
Diagnostic et prise en charge de la tumeur à cellules géantes ténosynoviale [Diagnosis and management of tenosynovial giant cell tumor]
Bakota-Morrison C., Strasser R., Letovanec I., Digklia A., Stamatiou A., Omoumi P., Cherix S., 2023/12/13. Revue medicale suisse, 19 (854) pp. 2330-2335. Peer-reviewed.
 
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q., Klein C., Caruso S., Maille P., Allende D.S., Mínguez B., Iavarone M., Ningarhari M., Casadei-Gardini A., Pedica F. et al., 2023/12. The Lancet. Oncology, 24 (12) pp. 1411-1422. Peer-reviewed.
Atypical cystic hepatorenal disease in a 40-year-old female: What is the diagnosis? A nephrology zebra.
Barbey F., Maillard M., Cina V., Fakhouri F., 2023/12. Journal of nephrology, 36 (9) pp. 2651-2653. Peer-reviewed.
Digital image analysis and artificial intelligence in pathology diagnostics-the Swiss view
Berezowska S., Cathomas G., Grobholz R., Henkel M., Jochum W., Koelzer V.H., Kreutzfeldt M., Mertz K.D., Rössle M., Soldini D. et al., 2023/12. Pathologie, 44 (Suppl 3) pp. 222-224. Peer-reviewed.
 
In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
Parras A., Vílchez-Acosta A., Desdín-Micó G., Picó S., Mrabti C., Montenegro-Borbolla E., Maroun C.Y., Haghani A., Brooke R., Del Carmen Maza M. et al., 2023/12. Nature aging, 3 (12) pp. 1509-1520. Peer-reviewed.
Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization.
Savage K.J., De Leval L., 2023/12/01. Haematologica, 108 (12) pp. 3204-3210. Peer-reviewed.
 
Invariant finding of non-clonal bone marrow lymphocytosis, with increased B cell component, in indolent systemic mastocytosis.
Papadopoulou V., Barcena-Garcia C., Basset V., Schoumans J., de Leval L., Schaller M., 2023/12. International journal of laboratory hematology, 45 (6) pp. 1007-1010. Peer-reviewed.
Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
Bisig B., Savage K.J., De Leval L., 2023/12/01. Haematologica, 108 (12) pp. 3227-3243. Peer-reviewed.
Pathologist Computer-Aided Diagnostic Scoring of Tumor Cell Fraction: A Swiss National Study.
Frei A.L., Oberson R., Baumann E., Perren A., Grobholz R., Lugli A., Dawson H., Abbet C., Lertxundi I., Reinhard S. et al., 2023/12. Modern pathology, 36 (12) p. 100335. Peer-reviewed.
Ryanodine receptor type 1 content decrease-induced endoplasmic reticulum stress is a hallmark of myopathies.
Vidal J., Fernandez E.A., Wohlwend M., Laurila P.P., Lopez-Mejia A., Ochala J., Lobrinus A.J., Kayser B., Lopez-Mejia I.C., Place N. et al., 2023/12. Journal of cachexia, sarcopenia and muscle, 14 (6) pp. 2882-2897. Peer-reviewed.
 
Standardized Classification of Lung Adenocarcinoma Subtypes and Improvement of Grading Assessment Through Deep Learning.
Lami K., Ota N., Yamaoka S., Bychkov A., Matsumoto K., Uegami W., Munkhdelger J., Seki K., Sukhbaatar O., Attanoos R. et al., 2023/12. The American journal of pathology, 193 (12) pp. 2066-2079. Peer-reviewed.
Was gibt es Neues bei der Klassifikation der peripheren T-Zell-Lymphomen? [What is new in the classification of peripheral T cell lymphomas?]
de Leval L., Bisig B., 2023/12. Pathologie, 44 (Suppl 3) pp. 128-135. Peer-reviewed.
Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation.
Schreiber F., Piontek G., Schneider-Kimoto Y., Schwarz-Furlan S., De Vito R., Locatelli F., Gengler C., Yoshimi A., Jung A., Klauschen F. et al., 2023/11/26. Cancers, 15 (23). Peer-reviewed.
Nitrogen isotopic composition as a gauge of tumor cell anabolism-to-catabolism ratio.
Straub M., Auderset A., de Leval L., Piazzon N., Maison D., Vozenin M.C., Ollivier J., Petit B., Sigman D.M., Martínez-García A., 2023/11/13. Scientific reports, 13 (1) p. 19796. Peer-reviewed.
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
Wang J., Sun N., Kunzke T., Shen J., Zens P., Prade V.M., Feuchtinger A., Berezowska S., Walch A., 2023/11/02. NPJ precision oncology, 7 (1) p. 114. Peer-reviewed.
 
An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.
Coukos A., Uldry E., Meylan S., Schmidt S., Fasquelle F., Sempoux C., Fraga M., 2023/11/01. The American journal of gastroenterology, 118 (11) p. 1920. Peer-reviewed.
Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol.
Schaer S., Rakauskas A., Dagher J., La Rosa S., Pensa J., Brisbane W., Marks L., Kinnaird A., Abouassaly R., Klein E. et al., 2023/11. World journal of urology, 41 (11) pp. 3325-3331. Peer-reviewed.
 
Biliary Tract Cancer: Molecular Biology of Precursor Lesions.
Manzano-Núñez F., Prates Tiago Aguilar L., Sempoux C., Lemaigre F.P., 2023/11. Seminars in liver disease, 43 (4) pp. 472-484. Peer-reviewed.
IL-21-IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection.
Pallikkuth S., Kvistad D., Sirupangi T., Kizhner A., Pahwa R., Cameron M.J., Richardson B., Williams S., Ayupe A., Brooks M. et al., 2023/11. Aging cell, 22 (11) pp. e13984. Peer-reviewed.
 
Prevalence of Pericardial Late Gadolinium Enhancement in Patients After Cardiac Surgery: Clinical and Histological Correlations.
Pavon A.G., Martinez Fernandez R., Arangalage D., Bergamaschi L., Maurizi N., Colombier S., Rotman S., Nowacka A., Bouchardy J., Schwitter J. et al., 2023/11. Circulation. Cardiovascular imaging, 16 (11) pp. e015606. Peer-reviewed.
Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report.
Wolf B., Dunet V., Dubruc E., Dolcan A., Nicod Lalonde M., Schiappacasse L., Zaman K., 2023/11. Case reports in oncology, 16 (1) pp. 1425-1435. Peer-reviewed.
The local microenvironment drives activation of neutrophils in human brain tumors.
Maas R.R., Soukup K., Fournier N., Massara M., Galland S., Kornete M., Wischnewski V., Lourenco J., Croci D., Álvarez-Prado Á.F. et al., 2023/10/12. Cell, 186 (21) pp. 4546-4566.e27. Peer-reviewed.
 
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.
Bobisse S., Bianchi V., Tanyi J.L., Sarivalasis A., Missiaglia E., Pétremand R., Benedetti F., Torigian D.A., Genolet R., Barras D. et al., 2023/10. Nature cancer, 4 (10) pp. 1410-1417. Peer-reviewed.
Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer.
Gaspar-Figueiredo S., Allemann P., Borgstein ABJ, Joliat G.R., Luzuy-Guarnero V., Brunel C., Sempoux C., Gisbertz S.S., Demartines N., van Berge Henegouwen M.I. et al., 2023/10. Journal of cancer research and clinical oncology, 149 (13) pp. 11105-11115. Peer-reviewed.
 
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
Dacic S., Travis W., Redman M., Saqi A., Cooper W.A., Borczuk A., Chung J.H., Glass C., Lopez J.M., Roden A.C. et al., 2023/10. Journal of thoracic oncology, 18 (10) pp. 1290-1302. Peer-reviewed.
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Decroos A., Cheminant M., Bruneau J., Carras S., Parinet V., Pelletier L., Lacroix L., Martin N., Giustiniani J., Lhermitte L. et al., 2023/10/01. Haematologica, 108 (10) pp. 2830-2836. Peer-reviewed.
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
Hofman P., Calabrese F., Kern I., Adam J., Alarcão A., Alborelli I., Anton N.T., Arndt A., Avdalyan A., Barberis M. et al., 2023/10. ESMO open, 8 (5) p. 101628. Peer-reviewed.
 
Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
Born T., Vassallo P., Golshayan D., Di Liberto G., Brouland J.P., Egervari K., Merkler D., Du Pasquier R.A., Bernard-Valnet R., 2023/09/26. Neurology, 101 (13) pp. e1382-e1386. Peer-reviewed.
Patterns of Carbon-Bound Exogenous Compounds Impact Disease Pathophysiology in Lung Cancer Subtypes in Different Ways.
Shen J., Sun N., Wang J., Zens P., Kunzke T., Buck A., Prade V.M., Wang Q., Feuchtinger A., Hu R. et al., 2023/09/12. ACS nano, 17 (17) pp. 16396-16411. Peer-reviewed.
PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas.
Cossu G., La Rosa S., Brouland J.P., Pitteloud N., Harel E., Santoni F., Brunner M., Daniel R.T., Messerer M., 2023/09/08. Cancers, 15 (18) p. 4471. Peer-reviewed.
Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
Di Napoli A., Soma L., Quintanilla-Martinez L., de Leval L., Leoncini L., Zamò A., Ng S.B., Ondrejka S.L., Climent F., Wotherspoon A. et al., 2023/09. Virchows Archiv, 483 (3) pp. 299-316. Peer-reviewed.
Correction to: Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop.
Di Napoli A., Soma L., Quintanilla-Martinez L., de Leval L., Leoncini L., Zamò A., Ng S.B., Ondrejka S.L., Climent F., Wotherspoon A. et al., 2023/09. Virchows Archiv, 483 (3) p. 435. Peer-reviewed.
Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Zamò A., van den Brand M., Climent F., de Leval L., Dirnhofer S., Leoncini L., Ng S.B., Ondrejka S.L., Quintanilla-Martinez L., Soma L. et al., 2023/09. Virchows Archiv, 483 (3) p. 437. Peer-reviewed.
Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
Climent F., Nicolae A., de Leval L., Dirnhofer S., Leoncini L., Ondrejka S.L., Soma L., Wotherspoon A., Zamo A., Quintanilla-Martinez L. et al., 2023/09. Virchows Archiv, 483 (3) pp. 333-348. Peer-reviewed.
Elevated liver function tests in a patient with breast cancer.
Neftel C., Zaman K., Chtioui H., Moradpour D., Sempoux C., Fraga M., 2023/09. Journal of hepatology, 79 (3) pp. e109-e111. Peer-reviewed.
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L., Laurent C., Soma L., Ng S.B., Climent F., Ondrejka S.L., Zamo A., Wotherspoon A., de Leval L., Dirnhofer S. et al., 2023/09. Virchows Archiv, 483 (3) pp. 281-298. Peer-reviewed.
 
EXABS-214-TCL New Insights Into the Pathogenesis of T-Cell Lymphoma and How This May Guide Treatment
de Leval Laurence, Bisig Bettina, 2023/09. Clinical Lymphoma Myeloma and Leukemia, 23 pp. S105-S106.
Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
Ondrejka S.L., Amador C., Climent F., Ng S.B., Soma L., Zamo A., Dirnhofer S., Quintanilla-Martinez L., Wotherspoon A., Leoncini L. et al., 2023/09. Virchows Archiv, 483 (3) pp. 349-365. Peer-reviewed.
 
Pathological features in non-neoplastic congenital and adult hyperinsulinism: from nesidioblastosis to current terminology and understanding.
Sempoux C., Klöppel G., 2023/09/01. Endocrine-related cancer, 30 (9) pp. e230034. Peer-reviewed.
 
POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma
Vallois David, Juilland Mélanie, Kalliopi Ioannidou, Lemmonier François, Missiaglia Edoardo, Bisig Bettina, Thome Margot, de Leval Laurence, 2023/09. pp. S214 dans Clinical Lymphoma Myeloma and Leukemia, Elsevier BV.
The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Zamò A., van den Brand M., Climent F., de Leval L., Dirnhofer S., Leoncini L., Ng S.B., Ondrejka S.L., Quintanilla-Martinez L., Soma L. et al., 2023/09. Virchows Archiv, 483 (3) pp. 317-331. Peer-reviewed.
Multilevel human secondary lymphoid immune system compartmentalization revealed by complementary imaging approaches.
Oyler B.L., Valencia-Dávila J.A., Moysi E., Molyvdas A., Ioannidou K., March K., Ambrozak D., De Leval L., Fabozzi G., Woods A.S. et al., 2023/08/18. iScience, 26 (8) p. 107261. Peer-reviewed.
Expanding the p.(Arg85Trp) Variant-Specific Phenotype of HNF4A: Features of Glycogen Storage Disease, Liver Cirrhosis, Impaired Mitochondrial Function, and Glomerular Changes.
Grassi M., Laubscher B., Pandey A.V., Tschumi S., Graber F., Schaller A., Janner M., Aeberli D., Hewer E., Nuoffer J.M. et al., 2023/08. Molecular syndromology, 14 (4) pp. 347-361. Peer-reviewed.
 
Nondestructive 3D pathology with analysis of nuclear features for prostate cancer risk assessment.
Serafin R., Koyuncu C., Xie W., Huang H., Glaser A.K., Reder N.P., Janowczyk A., True L.D., Madabhushi A., Liu J.T., 2023/08. The Journal of pathology, 260 (4) pp. 390-401. Peer-reviewed.
Overcoming the Interobserver Variability in Lung Adenocarcinoma Subtyping: A Clustering Approach to Establish a Ground Truth for Downstream Applications.
Lami K., Bychkov A., Matsumoto K., Attanoos R., Berezowska S., Brcic L., Cavazza A., English J.C., Fabro A.T., Ishida K. et al., 2023/08/01. Archives of pathology & laboratory medicine, 147 (8) pp. 885-895. Peer-reviewed.
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.
König D., Savic Prince S., Hayoz S., Zens P., Berezowska S., Jochum W., Stauffer E., Braunersreuther V., Trachsel B., Thierstein S. et al., 2023/07/11. ESMO open, 8 (4) p. 101595. Peer-reviewed.
 
Enigma portal: Undifferentiated thyroid malignant neoplasm in a patient with Hashimoto's thyroiditis.
Bárcena C., Muñoz-Hernández P., Adrados M., Jiménez-Heffernan J.A., 2023/07. Cytopathology, 34 (4) pp. 399-402. Peer-reviewed.
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.
Promsote W., Xu L., Hataye J., Fabozzi G., March K., Almasri C.G., DeMouth M.E., Lovelace S.E., Talana C.A., Doria-Rose N.A. et al., 2023/06/22. Nature communications, 14 (1) p. 3719. Peer-reviewed.
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Sibon D., Bisig B., Bonnet C., Poullot E., Bachy E., Cavalieri D., Fataccioli V., Bregnard C., Drieux F., Bruneau J. et al., 2023/06/01. Haematologica, 108 (6) pp. 1590-1603. Peer-reviewed.
Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
Barrera C., Corredor G., Viswanathan V.S., Ding R., Toro P., Fu P., Buzzy C., Lu C., Velu P., Zens P. et al., 2023/06/01. NPJ precision oncology, 7 (1) p. 52. Peer-reviewed.
Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas.
Maragkou T., Reinhard S., Jungo P., Pasquier B., Neuenschwander M., Schucht P., Vassella E., Hewer E., 2023/06. Pathology, 55 (4) pp. 466-477. Peer-reviewed.
 
Lack of smarcb1 expression characterizes a subset of peripheral t‐cell lymphomas enriched in children and young adults.
Fischer A., Moreno N., Interlandi M., Albert T. K., Mormann J., Glaser S., Patil P., Balbach S., Wagener R., Bens S. et al., 2023/06. pp. 192-192 dans Hematological Oncology, Wiley.
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.
Wischnewski V., Maas R.R., Aruffo P.G., Soukup K., Galletti G., Kornete M., Galland S., Fournier N., Lilja J., Wirapati P. et al., 2023/06. Nature cancer, 4 (6) pp. 908-924. Peer-reviewed.
The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis.
Deban M., Châtelain J., Fasquelle F., Clerc D., Toussaint L., Hübner M., Teixeira Farinha H., 2023/06. Pleura and peritoneum, 8 (2) pp. 75-81. Peer-reviewed.
MDCT-findings in patients with non-occlusive mesenteric ischemia (NOMI): influence of vasoconstrictor agents.
Topolsky A., Pantet O., Liaudet L., Sempoux C., Denys A., Knebel J.F., Schmidt S., 2023/05. European radiology, 33 (5) pp. 3627-3637. Peer-reviewed.
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Kraemer A.I., Chong C., Huber F., Pak H., Stevenson B.J., Müller M., Michaux J., Altimiras E.R., Rusakiewicz S., Simó-Riudalbas L. et al., 2023/05. Nature cancer, 4 (5) pp. 608-628. Peer-reviewed.
 
Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
John Gallon, Antonio Rodriguez-Calero, Andrej Benjak, Dilara Akhoundova, Sina Maletti, Ursula Amstutz, Ekkehard Hewer, Vera Genitsch, Achim Fleischmann, Elisabeth J. Rushing et al., 2023/04/14..
 
Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
John Gallon, Antonio Rodriguez-Calero, Andrej Benjak, Dilara Akhoundova, Sina Maletti, Ursula Amstutz, Ekkehard Hewer, Vera Genitsch, Achim Fleischmann, Elisabeth J. Rushing et al., 2023/04/14..
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
Kashani E., Schnidrig D., Gheinani A.H., Ninck M.S., Zens P., Maragkou T., Baumgartner U., Schucht P., Rätsch G., Rubin M.A. et al., 2023/04/06. Neuro-oncology, 25 (4) pp. 662-673. Peer-reviewed.
 
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
 
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
Effects of formalin fixation on polarimetric properties of brain tissue: fresh or fixed?
Gros R., Rodríguez-Núñez O., Felger L., Moriconi S., McKinley R., Pierangelo A., Novikova T., Vassella E., Schucht P., Hewer E. et al., 2023/04. Neurophotonics, 10 (2) p. 025009. Peer-reviewed.
Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
Haefliger S., Hench J., O'Rourke C.J., Meyer-Schaller N., Uzun S., Saldarriaga J., Weber A., Mazzucchelli L., Jermann P., Frank S. et al., 2023/04. Histopathology, 82 (5) pp. 722-730. Peer-reviewed.
MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology.
Sarkis R., Burri O., Royer-Chardon C., Schyrr F., Blum S., Costanza M., Cherix S., Piazzon N., Barcena C., Bisig B. et al., 2023/04. Modern pathology, 36 (4) p. 100088. Peer-reviewed.
Programmed death-ligand1 is a determinant of recurrence in alveolar echinococcosis.
Joliat G.R., Martins-Filho S.N., Haefliger S., Demartines N., Halkic N., Labgaa Ismail, Sempoux C., 2023/04. International journal of infectious diseases, 129 pp. 285-288. Peer-reviewed.
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity.
Sanalkumar R., Dong R., Lee L., Xing Y.H., Iyer S., Letovanec I., La Rosa S., Finzi G., Musolino E., Papait R. et al., 2023/03/31. Science advances, 9 (13) pp. eabo3789. Peer-reviewed.
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
Krebs F.S., Moura B., Missiaglia E., Aedo-Lopez V., Michielin O., Tsantoulis P., Bisig B., Trimech M., Zoete V., Homicsko K., 2023/02/24. International journal of molecular sciences, 24 (5) p. 4520. Peer-reviewed.
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J., Lemonnier F., Meydan C., Foox J., El Ghamrasni S., Mboumba D.L., Duncan G.S., Fortin J., Sakamoto T., Tobin C. et al., 2023/02/13. Cancer cell, 41 (2) pp. 323-339.e10. Peer-reviewed.
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
Yang H., Gao Y., Xu D., Xu K., Liang S.Q., Yang Z., Scherz A., Hall SRR, Forster S., Berezowska S. et al., 2023/02/10. Cell death discovery, 9 (1) p. 55. Peer-reviewed.
 
Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2−/BCL6− Nonrearranged Small B-Cell Lymphoid Neoplasms as Follicular or Nodal Marginal Zone Lymphoma.
Sesboue C., Galtier J., Jeanneau M., Chauvel A., Laharanne E., Amintas S., Merlio J.P., Bouabdallah K., Gros F.X., de Leval L. et al., 2023/02. Modern pathology, 36 (2) p. 100043. Peer-reviewed.
 
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Nesti C., Bräutigam K., Benavent M., Bernal L., Boharoon H., Botling J., Bouroumeau A., Brcic I., Brunner M., Cadiot G. et al., 2023/02. The Lancet. Oncology, 24 (2) pp. 187-194. Peer-reviewed.
Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.
Gonzalez-Farre B., Ramis-Zaldivar J.E., Castrejón de Anta N., Rivas-Delgado A., Nadeu F., Salmeron-Villalobos J., Enjuanes A., Karube K., Balagué O., Cobo F. et al., 2023/02/01. The American journal of surgical pathology, 47 (2) pp. 202-211. Peer-reviewed.
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Coukos A., Vionnet J., Sempoux C., Fraga M., 2023/02. Journal for immunotherapy of cancer, 11 (2) pp. e006877. Peer-reviewed.
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Álvarez-Prado Á.F., Maas R.R., Soukup K., Klemm F., Kornete M., Krebs F.S., Zoete V., Berezowska S., Brouland J.P., Hottinger A.F. et al., 2023/01/17. Cell reports. Medicine, 4 (1) p. 100900. Peer-reviewed.
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
Joo V., Petrovas C., de Leval L., Noto A., Obeid M., Fenwick C., Pantaleo G., 2023. Frontiers in immunology, 14 p. 1213375. Peer-reviewed.
Accessory and cavitated uterine masses: a case series and review of the literature.
Dekkiche S., Dubruc E., Kanbar M., Feki A., Mueller M., Meuwly J.Y., Mathevet P., 2023. Frontiers in reproductive health, 5 p. 1197931. Peer-reviewed.
 
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial.
Peters S., Letovanec I., Mauer M., Dafni U., Ejedepang D., Biernat W., Bubendorf L., Warth A., Pokharel S., Reinmuth N. et al., 2023/01. Lung cancer, 175 pp. 141-151. Peer-reviewed.
 
Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman A.L., Laurent C., Narbaitz M., Nakamura S., Chan W.C., de Leval L., Gaulard P., 2023/01. Virchows Archiv, 482 (1) pp. 265-279. Peer-reviewed.
Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A., Peters M., Martel P., van Rossum PSN, La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2023. PloS one, 18 (1) pp. e0280262. Peer-reviewed.
Editorial: CD4+ T cells in HIV: A Friend or a Foe?
Govindaraj S., Babu H., Kannanganat S., Vaccari M., Petrovas C., Velu V., 2023. Frontiers in immunology, 14 p. 1203531. Peer-reviewed.
Extranodal T- and NK-cell lymphomas.
de Leval L., Feldman A.L., Pileri S., Nakamura S., Gaulard P., 2023/01. Virchows Archiv, 482 (1) pp. 245-264. Peer-reviewed.
 
Immunohistochemical Detection of the Autophagy Markers LC3 and p62/SQSTM1 in Formalin-Fixed and Paraffin-Embedded Tissue.
Berezowska S., Galván J.A., 2023. pp. 133-139 dans Histochemistry of Single Molecules, Springer.
 
Immunohistochemical Detection of the Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Formalin-Fixed and Paraffin-Embedded Tissues.
Losmanová T., Tschan M.P., Galván J.A., Berezowska S., 2023. pp. 141-147 dans Histochemistry of Single Molecules, Springer.
Immunohistochemistry for hepatitis E virus capsid protein cross-reacts with cytomegalovirus-infected cells: a potential diagnostic pitfall.
Lenggenhager D., Grossmann J., Gouttenoire J., Sempoux C., Weber A., 2023/01. Histopathology, 82 (2) pp. 354-358. Peer-reviewed.
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
Veloza L., Cavalieri D., Missiaglia E., Ledoux-Pilon A., Bisig B., Pereira B., Bonnet C., Poullot E., Quintanilla-Martinez L., Dubois R. et al., 2023/01/01. Haematologica, 108 (1) pp. 181-195. Peer-reviewed.
 
Perioperative Management of a Patient With Combined Bernard Soulier syndrome and Storage Pool Disease During On-Pump Cardiac Surgery.
Christophel-Plathier E., Costanza M., Kirsch M., Dulguerov F., Chapuis-Bernasconi C., Bisig B., Verdy F., Mendes V., Rancati V., Alberio L. et al., 2023/01. Journal of cardiothoracic and vascular anesthesia, 37 (1) pp. 90-95. Peer-reviewed.
Prenatal Diagnosis of Gómez-López-Hernández Syndrome.
Pomar L., Rieder W., Dubruc E., Giuliano F., Atallah I., Lebon S., Vial Y., 2023. Fetal diagnosis and therapy, 50 (2) pp. 92-97. Peer-reviewed.
 
Prenatal magnetic resonance imaging of complex female genitourinary system abnormalities, what the fetal medicine specialist needs to know.
Alamo L., Gengler C., Hanquinet S., Rougemont A.L., Meuwly J.Y., 2023/01. Prenatal diagnosis, 43 (1) pp. 84-94. Peer-reviewed.
The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation.
Suter Y., Knecht U., Valenzuela W., Notter M., Hewer E., Schucht P., Wiest R., Reyes M., 2022/12/15. Scientific data, 9 (1) p. 768. Peer-reviewed.
 
HHV8-negative primary effusion-based large B-cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1-positive under dasatinib treatment: Report of a new case and literature review.
Christe L., Veloza L., Gros L., Bisig B., Blum S., Hewer E., de Leval L., 2022/12. Diagnostic cytopathology, 50 (12) pp. E351-E356. Peer-reviewed.
Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
Diebold M., Locher E., Boide P., Enzler-Tschudy A., Faivre A., Fischer I., Helmchen B., Hopfer H., Kim M.J., Moll S. et al., 2022/12. Kidney international, 102 (6) pp. 1409-1419. Peer-reviewed.
 
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma.
Calderaro J., Di Tommaso L., Maillé P., Beaufrère A., Nguyen C.T., Heij L., Gnemmi V., Graham R.P., Charlotte F., Chartier S. et al., 2022/12. Journal of hepatology, 77 (6) pp. 1586-1597. Peer-reviewed.
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer.
Zens P., Bello C., Scherz A., von Gunten M., Ochsenbein A., Schmid R.A., Berezowska S., 2022/12. Modern pathology, 35 (12) pp. 1848-1859. Peer-reviewed.
 
Genomic profiling for clinical decision making in lymphoid neoplasms.
de Leval L., Alizadeh A.A., Bergsagel P.L., Campo E., Davies A., Dogan A., Fitzgibbon J., Horwitz S.M., Melnick A.M., Morice W.G. et al., 2022/11/24. Blood, 140 (21) pp. 2193-2227. Peer-reviewed.
Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy.
Pataer A., Weissferdt A., Correa A.M., Vaporciyan A.A., Sepesi B., Heymach J.V., Berezowska S., Cascone T., Swisher S.G., 2022/11. JTO clinical and research reports, 3 (11) p. 100420. Peer-reviewed.
Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases-a Single-Center Study in 190 Patients.
Kündig A., Zens P., Fung C., Scherz A., Cerciello F., Herrmann E., Ermis E., Schmid R.A., Vassella E., Berezowska S., 2022/11. JTO clinical and research reports, 3 (11) p. 100413. Peer-reviewed.
Women with Cervical High-Risk Human Papillomavirus: Be Aware of Your Anus! The ANGY Cross-Sectional Clinical Study.
Jacot-Guillarmod M., Balaya V., Mathis J., Hübner M., Grass F., Cavassini M., Sempoux C., Mathevet P., Pache B., 2022/10/18. Cancers, 14 (20) p. 5096. Peer-reviewed.
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer.
Digklia A., Boughdad S., Homicsko K., Dromain C., Trimech M., Dolcan A., Peters S., Prior J., Schaefer N., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005383. Peer-reviewed.
Porto-sinusoidal vascular disorder.
De Gottardi A., Sempoux C., Berzigotti A., 2022/10. Journal of hepatology, 77 (4) pp. 1124-1135. Peer-reviewed.
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
Towards a national strategy for digital pathology in Switzerland.
Janowczyk A., Baumhoer D., Dirnhofer S., Grobholz R., Kipar A., de Leval L., Merkler D., Michielin O., Moch H., Perren A. et al., 2022/10. Virchows Archiv, 481 (4) pp. 647-652. Peer-reviewed.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Campo E., Jaffe E.S., Cook J.R., Quintanilla-Martinez L., Swerdlow S.H., Anderson K.C., Brousset P., Cerroni L., de Leval L., Dirnhofer S. et al., 2022/09/15. Blood, 140 (11) pp. 1229-1253. Peer-reviewed.
MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver.
Gjorgjieva M., Ay A.S., Correia de Sousa M., Delangre E., Dolicka D., Sobolewski C., Maeder C., Fournier M., Sempoux C., Foti M., 2022/09/14. Cells, 11 (18) p. 2860. Peer-reviewed.
 
Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation.
Lorusso G., Wyss C.B., Kuonen F., Vannini N., Billottet C., Duffey N., Pineau R., Lan Q., Wirapati P., Barras D. et al., 2022/09/07. Science translational medicine, 14 (661) pp. eaax8933. Peer-reviewed.
 
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.
Ventura-Cots M., Argemi J., Jones P.D., Lackner C., El Hag M., Abraldes J.G., Alvarado E., Clemente A., Ravi S., Alves A. et al., 2022/09. Gut, 71 (9) pp. 1856-1866. Peer-reviewed.
EBV-associated NK and T-cell lymphoid neoplasms.
Kimura H., de Leval L., Cai Q., Kim W.S., 2022/09/01. Current opinion in oncology, 34 (5) pp. 422-431. Peer-reviewed.
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV.
Di Liberto G., Egervari K., Kreutzfeldt M., Schürch C.M., Hewer E., Wagner I., Du Pasquier R., Merkler D., 2022/08/27. Brain, 145 (8) pp. 2730-2741. Peer-reviewed.
HPV-negative Penile Intraepithelial Neoplasia (PeIN) With Basaloid Features.
Guerrero J., Trias I., Veloza L., Del Pino M., Garcia A., Marimon L., Diaz-Mercedes S., Rodrigo-Calvo M.T., Alós S., Ajami T. et al., 2022/08/01. The American journal of surgical pathology, 46 (8) pp. 1071-1077. Peer-reviewed.
 
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A., Bouilly J., Lara D., Fataccioli V., Lemonnier F., Drieux F., Parrens M., Robe C., Poullot E., Bisig B. et al., 2022/08. Modern pathology, 35 (8) pp. 1126-1136. Peer-reviewed.
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.
Artru F., Vietti-Violi N., Sempoux C., Vieira Barbosa J., Becce F., Sah N., Marot A., Deltenre P., Moschouri E., Fraga M. et al., 2022/08. JHEP reports, 4 (8) p. 100511. Peer-reviewed.
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
Evangelou K., Veroutis D., Paschalaki K., Foukas P.G., Lagopati N., Dimitriou M., Papaspyropoulos A., Konda B., Hazapis O., Polyzou A. et al., 2022/08. The European respiratory journal, 60 (2) p. 2102951. Peer-reviewed.
Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms.
Hytiroglou P., Bioulac-Sage P., Theise N.D., Sempoux C., 2022/07/28. Cancers, 14 (15) p. 3670. Peer-reviewed.
Synchronous or collision solid neoplasms and lymphomas: A systematic review of 308 case reports.
Parra-Medina R., Rocha F., Castañeda-González J.P., Moreno-Lucero P., Veloza L., Romero-Rojas A.E., 2022/07/15. Medicine, 101 (28) pp. e28988. Peer-reviewed.
A hypervascular liver mass.
Lázaro-Fontanet E., Maillard M., Fasquelle F., Vietti-Violi N., Labgaa I., Uldry E., 2022/07. Surgery, 172 (1) pp. e5-e6. Peer-reviewed.
BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
Ghosh T., Greipp P.T., Knutson D., Kloft-Nelson S., Jenkins S., Mounajjed T., Said S., La Rosa S., Vanoli A., Sessa F. et al., 2022/07/01. Archives of pathology & laboratory medicine, 146 (7) pp. 840-845. Peer-reviewed.
Quantitative Analysis of the MGMT Methylation Status of Glioblastomas in Light of the 2021 WHO Classification.
Häni L., Kopcic M., Branca M., Schütz A., Murek M., Söll N., Vassella E., Raabe A., Hewer E., Schucht P., 2022/06/27. Cancers, 14 (13) p. 3149. Peer-reviewed.
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome.
Ding R., Prasanna P., Corredor G., Barrera C., Zens P., Lu C., Velu P., Leo P., Beig N., Li H. et al., 2022/06/03. NPJ precision oncology, 6 (1) p. 33. Peer-reviewed.
Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases.
Vanoli A., Grami O., Klersy C., Milanetto A.C., Albarello L., Fassan M., Luchini C., Grillo F., Spaggiari P., Inzani F. et al., 2022/06. Endocrine pathology, 33 (2) pp. 274-288. Peer-reviewed.
Early-onset leukoencephalomyelopathy due to a biallelic NDUFV1 variant in a mid-forties patient.
Gschwind M., Garcia Segarra N., Schaller A., Bolognini R., Nuoffer J.M., Hourez R., Deprez M., Lhermitte B., Maeder P., Tran C. et al., 2022/06. Annals of clinical and translational neurology, 9 (6) pp. 888-892. Peer-reviewed.
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
Mark M., Rusakiewicz S., Früh M., Hayoz S., Grosso F., Pless M., Zucali P., Ceresoli G.L., Maconi A., Schneider M. et al., 2022/06. ESMO open, 7 (3) p. 100446. Peer-reviewed.
Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients.
Shen J., Sun N., Zens P., Kunzke T., Buck A., Prade V.M., Wang J., Wang Q., Hu R., Feuchtinger A. et al., 2022/06. Cancer communications, 42 (6) pp. 517-535. Peer-reviewed.
 
The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2022/06. Progres en urologie, 32 (6S1) pp. 6S26-6S32. Peer-reviewed.
The EHA Research Roadmap: Malignant Lymphoid Diseases.
Dreyling M., André M., Gökbuget N., Tilly H., Jerkeman M., Gribben J., Ferreri A., Morel P., Stilgenbauer S., Fox C. et al., 2022/06. HemaSphere, 6 (6) pp. e726. Peer-reviewed.
Alterations in homologous recombination repair genes in prostate cancer brain metastases.
Rodriguez-Calero A., Gallon J., Akhoundova D., Maletti S., Ferguson A., Cyrta J., Amstutz U., Garofoli A., Paradiso V., Tomlins S.A. et al., 2022/05/03. Nature communications, 13 (1) p. 2400. Peer-reviewed.
Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.
Bernier-Latmani J., Cisarovsky C., Mahfoud S., Ragusa S., Dupanloup I., Barras D., Renevey F., Nassiri S., Anderle P., Squadrito M.L. et al., 2022/05. Nature cardiovascular research, 1 (5) pp. 476-490. Peer-reviewed.
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
Santos A., Desgranges F., Jovanovic M., Anichini A., Kritikos A., Dunet V., Brouland J.P., Théaudin M., Pot C., Du Pasquier R. et al., 2022/05. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 49 (3) pp. 445-451. Peer-reviewed.
Hepatocellular adenoma: what we know, what we do not know, and why it matters.
Bioulac-Sage P., Gouw ASH, Balabaud C., Sempoux C., 2022/05. Histopathology, 80 (6) pp. 878-897. Peer-reviewed.
 
Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses.
Moysi E., Paris R.M., Le Grand R., Koup R.A., Petrovas C., 2022/05. Expert review of vaccines, 21 (5) pp. 633-644. Peer-reviewed.
Endoscope-Assisted Extreme Lateral Supracerebellar Infratentorial Approach for Resection of Superior Cerebellar Peduncle Pilocytic Astrocytoma: Technical Note.
Papadimitriou K., Cossu G., Hewer E., Diezi M., Daniel R.T., Messerer M., 2022/04/29. Children, 9 (5) p. 640. Peer-reviewed.
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.
Möller E., Praz V., Rajendran S., Dong R., Cauderay A., Xing Y.H., Lee L., Fusco C., Broye L.C., Cironi L. et al., 2022/04/27. Nature communications, 13 (1) p. 2267. Peer-reviewed.
Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors.
Tak Y.E., Boulay G., Lee L., Iyer S., Perry N.T., Schultz H.T., Garcia S.P., Broye L., Horng J.E., Rengarajan S. et al., 2022/04/13. Cell genomics, 2 (4) p. 100119. Peer-reviewed.
The Octopus Sign-A New HRCT Sign in Pulmonary Langerhans Cell Histiocytosis.
Poellinger A., Berezowska S., Myers J.L., Huber A., Funke-Chambour M., Guler S., Geiser T., Harari S., Caminati A., Zompatori M. et al., 2022/04/08. Diagnostics, 12 (4) p. 937. Peer-reviewed.
Lymphoid Enhancer-Binding Factor 1 (LEF1) immunostaining as a surrogate of β-Catenin (CTNNB1) mutations
Ekkehard H., Pascal F., Erik V., Laura K., Sara I., Mueller MD, Rau TT, Dettmer MS, 2022/04/02..
Prenatal diagnosis of Aicardi syndrome based on a suggestive imaging pattern: A multicenter case-series.
Pomar L., Ochoa J., Cabet S., Huisman TAGM, Paladini D., Klaritsch P., Galmiche A., Prayer F., Gacio S., Haratz K. et al., 2022/04. Prenatal diagnosis, 42 (4) pp. 484-494. Peer-reviewed.
 
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.
Wu W., Nelson G.M., Koch R., Donovan K.A., Nowak R.P., Heavican-Foral T.B., Nirmal A.J., Liu H., Yang L., Duffy J. et al., 2022/03/31. Blood, 139 (13) pp. 2024-2037. Peer-reviewed.
TIA1 Loss Exacerbates Fatty Liver Disease but Exerts a Dual Role in Hepatocarcinogenesis.
Dolicka D., Zahoran S., Correia de Sousa M., Gjorgjieva M., Sempoux C., Fournier M., Maeder C., Collart M.A., Foti M., Sobolewski C., 2022/03/27. Cancers, 14 (7) p. 1704. Peer-reviewed.
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversification.
Descatoire M., Fritzen R., Rotman S., Kuntzelman G., Leber X.C., Droz-Georget S., Thrasher A.J., Traggiai E., Candotti F., 2022/03/08. Cell reports, 38 (10) p. 110474. Peer-reviewed.
Code of practice for medical autopsies: a minimum standard position paper for pathology departments performing medical (hospital) autopsies in adults.
Alfsen G.C., Gulczyński J., Kholová I., Latten B., Martinez J., Metzger M., Michaud K., Pontinha C.M., Rakislova N., Rotman S. et al., 2022/03. Virchows Archiv, 480 (3) pp. 509-517. Peer-reviewed.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C. et al., 2022/03. Nature, 603 (7899) pp. 145-151. Peer-reviewed.
Venetoclax combined with FLAG-based chemotherapy induces an early and deep response in mixed-phenotype-acute leukemia.
Ségot A., Stalder G., de Leval L., Solly F., Schoumans J., Basset V., Blum S., Spertini O., 2022/03/01. American journal of hematology, 97 (3) pp. E91-E93. Peer-reviewed.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F., Bruscaggin A., Guidetti F., Terzi di Bergamo L., Faderl M., Spina V., Condoluci A., Bonomini L., Forestieri G., Koch R. et al., 2022/02/03. Blood, 139 (5) pp. 732-747. Peer-reviewed.
Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma.
Laribi K., Baugier de Materre A., Touileb Y., Boursot C., Sandrini J., Cavalieri D., Pastoret C., de Leval L., Tournilhac O., 2022/02. HemaSphere, 6 (2) pp. e675. Peer-reviewed.
Erratum zu: Standardisierte strukturierte Befundberichte gastrointestinaler Tumoren.
Hewer E., Rump A., Langer R., 2022/02. Der Pathologe, 43 (1) pp. 63-64. Peer-reviewed.
Isolated skin infiltration by a blastic plasmacytoid dendritic cell neoplasm.
Stalder G., Milowich D., Blum S., Schoumans J., Bisig B., Spertini O., 2022/02. EJHaem, 3 (1) pp. 259-260. Peer-reviewed.
Oligosarcomas, IDH-mutant are distinct and aggressive.
Suwala A.K., Felix M., Friedel D., Stichel D., Schrimpf D., Hinz F., Hewer E., Schweizer L., Dohmen H., Pohl U. et al., 2022/02. Acta neuropathologica, 143 (2) pp. 263-281. Peer-reviewed.
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
Houot R., Poeschel V., Altmann B., Angel S., Thurner L., Illmer T., Andre M., Dreyling M., Maisonneuve H., Tilly H. et al., 2022/02. HemaSphere, 6 (2) pp. e672. Peer-reviewed.
Role of immunohistochemistry for interobserver agreement of Peritoneal Regression Grading Score in peritoneal metastasis.
Detlefsen S., Windedal T., Bibeau F., Bruhn L.V., Carr N., Graversen M., Markowski K., Mortensen M.B., Neureiter D., Sempoux C. et al., 2022/02. Human pathology, 120 pp. 77-87. Peer-reviewed.
Standardisierte strukturierte Befundberichte gastrointestinaler Tumoren [Standardized structured reports for gastrointestinal tumors]
Hewer E., Rump A., Langer R., 2022/02. Der Pathologe, 43 (1) pp. 57-62. Peer-reviewed.
 
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).
Bachy E., Camus V., Thieblemont C., Sibon D., Casasnovas R.O., Ysebaert L., Damaj G., Guidez S., Pica G.M., Kim W.S. et al., 2022/01/20. Journal of clinical oncology, 40 (3) pp. 242-251. Peer-reviewed.
Has the profile of heart transplantation recipients changed within the last three decades?
Anouck Z., Tozzi P., Regamey J., Abdurashidova T., Meyer P., Lefol K., Pascual M., Yerly P., Aubert V., Aur S. et al., 2022/01/17. Swiss medical weekly, 152 pp. w30108. Peer-reviewed.
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J., Clerbaux L.A., Nachit M., Sempoux C., Staels B., Bindels L.B., Tailleux A., Leclercq I.A., 2022/01. JHEP reports, 4 (1) p. 100387. Peer-reviewed.
Case Report: Tyrosine Kinase Inhibitors Induced Lymphadenopathy in Desmoid Tumor Patients.
Papadopoulos S., Koulouris P., Royer-Chardon C., Tsoumakidou G., Dolcan A., Cherix S., Matter M., Omoumi P., Digklia A., 2022. Frontiers in endocrinology, 13 p. 794512. Peer-reviewed.
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
Yerly P., Rotman S., Regamey J., Aubert V., Aur S., Kirsch M., Hullin R., Pascual M., 2022/01. Xenotransplantation, 29 (1) pp. e12726. Peer-reviewed.
COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic.
Fortarezza F., Pezzuto F., Hofman P., Kern I., Panizo A., von der Thüsen J., Timofeev S., Gorkiewicz G., Berezowska S., de Leval L. et al., 2022/01/01. Diagnostics, 12 (1) p. 95. Peer-reviewed.
Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature.
Diciolla A., Gianoni M., Fleury M., Szturz P., Demartines N., Peters S., Duran R., Desseauve D., Panchaud M.A., Fasquelle F. et al., 2022. Frontiers in oncology, 12 p. 1006387. Peer-reviewed.
Hierarchical graph representations in digital pathology.
Pati P., Jaume G., Foncubierta-Rodríguez A., Feroce F., Anniciello A.M., Scognamiglio G., Brancati N., Fiche M., Dubruc E., Riccio D. et al., 2022/01. Medical image analysis, 75 p. 102264. Peer-reviewed.
Histological regression of peritoneal metastases of recurrent tubo-ovarian cancer after systemic chemotherapy.
Pache B., Teixeira Farinha H., Toussaint L., Demartines N., Hastir D., Mathevet P., Sempoux C., Hübner M., 2022. Frontiers in surgery, 9 p. 936613. Peer-reviewed.
Iberogast®-Induced Acute Liver Injury—A Case Report
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart PA, 2022. Gastro Hep Advances, 1 (4) pp. 601-603.
 
Intraoperative confocal laser endomicroscopy for brain tumors - potential and challenges from a neuropathological perspective.
Maragkou T., Quint K., Pollo B., Hewer E., 2022/01. Free neuropathology, 3 pp. 3-24. Peer-reviewed.
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A., Uccella S., Marchiori D., La Rosa S., Daraspe J., Balmas Bourloud K., Beck Popovic M., Eugster P.J., Grouzmann E., Abid K., 2022. Frontiers in endocrinology, 13 p. 1027856. Peer-reviewed.
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
Herrera F.G., Ronet C., Ochoa de Olza M., Barras D., Crespo I., Andreatta M., Corria-Osorio J., Spill A., Benedetti F., Genolet R. et al., 2022/01. Cancer discovery, 12 (1) pp. 108-133. Peer-reviewed.
Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature.
Deslarzes P., Djafarrian R., Matter M., La Rosa S., Gengler C., Beck-Popovic M., Zingg T., 2022. Frontiers in pediatrics, 10 p. 869518. Peer-reviewed.
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome.
Atallah I., McCormick D., Good J.M., Barigou M., Fraga M., Sempoux C., Superti-Furga A., Semple R.K., Tran C., 2022. Journal of clinical lipidology, 16 (5) pp. 583-590. Peer-reviewed.
Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
Pache B., Balaya V., Mathis J., Hübner M., Sahli R., Cavassini M., Sempoux C., Mathevet P., Jacot-Guillarmod M., 2022. PloS one, 17 (10) pp. e0276438. Peer-reviewed.
Rare Presentation of Rosai-Dorfman Disease in Soft Tissue: Diagnostic Findings and Surgical Treatment.
Betini N., Munger A.M., Rottmann D., Haims A., Costa J., Lindskog D.M., 2022. Case reports in surgery, 2022 p. 8440836. Peer-reviewed.
 
Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans.
Bräutigam K., Reinhard S., Galván J.A., Wartenberg M., Hewer E., Schürch C.M., 2022. Respiration; international review of thoracic diseases, 101 (6) pp. 610-618. Peer-reviewed.
 
Thanks to the Reviewers of <i>The Pathologist</i>
Hewer Ekkehard, 2022..
Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
Ribera-Cortada I., Guerrero-Pineda J., Trias I., Veloza L., Garcia A., Marimon L., Diaz-Mercedes S., Alamo J.R., Rodrigo-Calvo M.T., Vega N. et al., 2021/12/27. International journal of molecular sciences, 23 (1) p. 251. Peer-reviewed.
Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript.
Voruz S., Blum S., de Leval L., Schoumans J., Solly F., Spertini O., 2021/12/20. Biomarker research, 9 (1) p. 92. Peer-reviewed.
 
A 31-Year-Old Patient Living With Human Immunodeficiency Virus With Thyroiditis and Multiple Intrathoracic Lesions.
Filippidis P., Barras J.L., Cavassini M., Kritikos A., 2021/12/16. Clinical infectious diseases, 73 (12) pp. 2361-2364. Peer-reviewed.
Decreased Fetal Movements: A Sign of Placental SARS-CoV-2 Infection with Perinatal Brain Injury.
Favre G., Mazzetti S., Gengler C., Bertelli C., Schneider J., Laubscher B., Capoccia R., Pakniyat F., Ben Jazia I., Eggel-Hort B. et al., 2021/12/15. Viruses, 13 (12) p. 2517. Peer-reviewed.
 
A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.
Gonzalez Melo M., Fontana A.O., Viertl D., Allenbach G., Prior J.O., Rotman S., Feichtinger R.G., Mayr J.A., Costanzo M., Caterino M. et al., 2021/12. Molecular genetics and metabolism, 134 (4) pp. 287-300. Peer-reviewed.
 
ASO Visual Abstract: The ‘Real R0': A Resection Margin < 0.1 cm is Associated with Poor Prognosis After Oncological Esophagectomy
St-Amour P., Winiker M., Sempoux C., Fasquelle F., Demartines N., Schäfer M., Mantziari S., 2021/12. Annals of Surgical Oncology, 28 (S3) pp. 497-498. Peer-reviewed.
Infirmière clinicienne de centre du cancer : l’expérience du Centre de la prostate du CHUV [Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Codeluppi C., Ninane F., Jolliet L., Glemarec P., Orcurto A., Rakauskas A., Tawadros T., Bosshard P., Eicher M., Herrera F. et al., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2082-2085. Peer-reviewed.
 
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal M.R., François A., Altinay S., Arnould L., Balkenhol M., Broeckx G., Burguès O., Colpaert C., Dedeurwaerdere F., Dessauvagie B. et al., 2021/12. Modern pathology, 34 (12) pp. 2130-2140. Peer-reviewed.
Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations.
Vassella E., Kashani E., Zens P., Kündig A., Fung C., Scherz A., Herrmann E., Ermis E., Schmid R.A., Berezowska S., 2021/12. European journal of cancer, 159 pp. 227-236. Peer-reviewed.
Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology.
Kunzke T., Prade V.M., Buck A., Sun N., Feuchtinger A., Matzka M., Fernandez I.E., Wuyts W., Ackermann M., Jonigk D. et al., 2021/12/01. Cancer research, 81 (23) pp. 5862-5875. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University